SCHOTT Pharma AG & Co KgaA banner

SCHOTT Pharma AG & Co KgaA
F:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA Logo
SCHOTT Pharma AG & Co KgaA
F:1SXP
Watchlist
Price: 14.54 EUR -1.49% Market Closed
Market Cap: €2.2B

EV/IC

1.5
Current
53%
Cheaper
vs 3-y average of 3.2

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
1.5
=
Enterprise Value
€2.2B
/
Invested Capital
€1.5B

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
1.5
=
Enterprise Value
€2.2B
/
Invested Capital
€1.5B

Valuation Scenarios

SCHOTT Pharma AG & Co KgaA is trading below its 3-year average

If EV/IC returns to its 3-Year Average (3.2), the stock would be worth €30.88 (112% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-43%
Maximum Upside
+112%
Average Upside
37%
Scenario EV/IC Value Implied Price Upside/Downside
Current Multiple 1.5 €14.54
0%
3-Year Average 3.2 €30.88
+112%
5-Year Average 3.2 €30.88
+112%
Industry Average 0.9 €8.29
-43%
Country Average 1 €9.37
-36%

Forward EV/IC
Today’s price vs future invested capital

Not enough data available to calculate forward EV/IC

Peer Comparison

All Multiples
EV/IC
P/E
All Countries
Close

Market Distribution

In line with most companies in Germany
Percentile
67th
Based on 2 708 companies
67th percentile
1.5
Low
0 — 0.6
Typical Range
0.6 — 1.6
High
1.6 —
Distribution Statistics
Germany
Min 0
30th Percentile 0.6
Median 1
70th Percentile 1.6
Max 298.9

SCHOTT Pharma AG & Co KgaA
Glance View

SCHOTT Pharma AG & Co KgaA, carved from the renowned SCHOTT AG, stands as a beacon in the pharmaceutical packaging industry. With roots deeply embedded in scientific glass manufacturing, SCHOTT Pharma specializes in providing sophisticated solutions for the containment and delivery of medicines. Their core expertise revolves around the development and production of high-quality glass and polymer products, including pre-fillable syringes, vials, and cartridges. These products are meticulously crafted to meet the stringent safety and quality demands of the healthcare sector, ensuring optimal preservation and delivery of pharmaceutical substances. The company leverages its profound understanding of material science, coupled with a focus on innovation, to offer tailored solutions to pharmaceutical companies across the globe. SCHOTT Pharma's business model thrives on collaboration and partnership with its clients, ensuring their specific needs are met with precision. The firm earns its revenue by forging long-term relationships with leading pharmaceutical players, supplying them with specialized containers designed to enhance drug stability and extend shelf life. This relationship is symbiotic, as SCHOTT Pharma not only provides the physical packaging but also lends its expertise in regulatory compliance and product testing, thereby positioning itself as a crucial contributor to its clients' overall success. By investing deeply in research and development, SCHOTT Pharma continues to innovate, maintaining its competitive edge and ensuring consistent demand for its high-performance pharmaceutical packaging solutions.

1SXP Intrinsic Value
28.78 EUR
Undervaluation 49%
Intrinsic Value
Price €14.54
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett